Effect of nicardipine prolonged-release implants on cerebral vasospasm and clinical outcome after severe aneurysmal subarachnoid hemorrhage: A prospective, randomized, double-blind phase IIa study

Stroke

Volumn 38, Issue 2, 2007, Pages 330-336

  Barth, Martin ^a   Capelle, Hans Holger ^a   Weidauer, Stephan ^b   Weiss, Christel ^a   Münch, Elke ^a   Thomé, Claudius ^a   Luecke, Thomas ^a   Schmiedek, Peter ^a   Kasuya, Hidetoshi ^c   Vajkoczy, Peter ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b GOETHE UNIVERSITY   (Germany)

^c TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Nicardipine prolonged release implants; SAH; Stroke; Vasospasm

Indexed keywords

LOW MOLECULAR WEIGHT HEPARIN; NICARDIPINE;

ABSENCE OF SIDE EFFECTS; ADULT; ANEURYSM; ANEURYSM CLIP; ARTICLE; BRAIN ANGIOGRAPHY; BRAIN BLOOD VESSEL; BRAIN ISCHEMIA; BRAIN VASOSPASM; CISTERNA MAGNA; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROL GROUP; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG IMPLANT; DRUG TOLERABILITY; FEMALE; HEALTH CARE ORGANIZATION; HUMAN; INCIDENCE; MALE; NEUROIMAGING; PHASE 2 CLINICAL TRIAL; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SLOW DRUG RELEASE; SUBARACHNOID HEMORRHAGE; THROMBOEMBOLISM; TREATMENT OUTCOME;

ADULT; DELAYED-ACTION PREPARATIONS; DOUBLE-BLIND METHOD; DRUG IMPLANTS; FEMALE; HUMANS; INTRACRANIAL ANEURYSM; MIDDLE AGED; NICARDIPINE; PROSPECTIVE STUDIES; SUBARACHNOID HEMORRHAGE; TIME FACTORS; TREATMENT OUTCOME; VASOSPASM, INTRACRANIAL;

EID: 33846697939     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000254601.74596.0f     Document Type: Article

References (19)

1. Macdonald RL, Weir BK. Cerebral Vasospasm. San Diego: Academic; 2001.
2. Kawashima A, Kasuya H, Sashara A, Miyajima M, Izawa M, Hori T. Prevention of cerebral vasospasm by nicardipine prolonged-release implants in dogs. Neurol Res. 2000;22:634-641.
3. Kasuya H, Onda H, Sasahara A, Kawashima A, Takeshita M, Okada Y, Hori T. Efficacy and safety of nicardipine prolonged-release implants for preventing vasospasm in humans. Stroke. 2002;33:1011-1015.
4. Kasuya H, Onda H, Sasahara A, Takeshita M, Hori T. Application of nicardipine prolonged-release implants: analysis of 97 consecutive patients with acute subarachnoid hemorrhage. Neurosurgery. 2005;56:895-902; discussion 895-902.
5. Macdonald RL. Editorial comment. Neurosurgery. 2005;56:902.
6. Weir B, Grace M, Hansen J, Rothberg C. Time course of vasospasm in man. J Neurosurg. 1978;48:173-178.
7. Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Meas. 1960;20:37-46.
8. Cohen J. Weighted kappa: Nominal scale agreement with provision for scaled disagreement or partial credit. Psychol Bull. 1968;70:213-220.
9. Dietrich HH, Dacey RG Jr. Molecular keys to the problems of cerebral vasospasm. Neurosurgery. 2000;46:517-530.
10. Laher I, Zhang JH. Protein kinase c and cerebral vasospasm. J Cereb Blood Flow Metab. 2001;21:887-906.
11. Macdonald RL, Zhang ZD, Takahashi M, Nikitina E, Young JB, Xie A, Larkin L. Calcium sensitivity of vasospastic basilar artery after experimental subarachnoid hemorrhage. Am J Physiol Heart Circ Physiol. 2006;290:2329-2336.
12. Pickard JD, Murray GD, Illingworth R, Shaw MD, Teasdale GM, Foy PM, Humphrey PR, Lang DA, Nelson R, Richards P. Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial. BMJ. 1989;298:636-642.
13. Ohman J, Servo A, Heiskanen O. Long-term effects of nimodipine on cerebral infarcts and outcome after aneurysmal subarachnoid hemorrhage and surgery. J Neurosurg. 1991;74:8-13.
14. Barker II FG, Ogilvy CS. Efficacy of prophylactic nimodipine for delayed ischemic deficit after subarachnoid hemorrhage: a metaanalysis. J Neurosurg. 1996;84:405-414.
15. Badjatia N, Topcuoglu MA, Pryor JC, Rabinov JD, Ogilvy CS, Carter BS, Rordorf GA. Preliminary experience with intra-arterial nicardipine as a treatment for cerebral vasospasm. AJNR Am J Neuroradiol. 2004;25:819-826.
16. Firat MM, Gelebek V, Orer HS, Belen D, Firat AK, Balkanci F. Selective intraarterial nimodipine treatment in an experimental subarachnoid hemorrhage model. AJNR Am J Neuroradiol. 2005;26:1357-1362.
17. Shibuya M, Suzuki Y, Enomoto H, Okada T, Ogura K, Sugita K. Effects of prophylactic intrathecal administrations of nicardipine on vasospasm in patients with severe aneurysmal subarachnoid haemorrhage. Acta Neurochir. 1994;131:19 -25.
18. Suzuki M, Doi M, Otawara Y, Ogasawara K, Ogawa A. Intrathecal administration of nicardipine hydrochloride to prevent vasospasm in patients with subarachnoid hemorrhage. Neurosurg Rev. 2001;24:180-184.
19. Michel AD, Whiting RL. Cellular action of nicardipine. Am J Cardiol. 1989;64:3H-7H.